newsfilter
← Latest News
GlobeNewswire·

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates

Primary endpoint met in Phase 2b trial with GH001 in TRD demonstrating -15.5 Point placebo-adjusted MADRS reductionFull response to the IND hold on track for submission in mid-2025Cash, cash equivalents, other financial